EarlySense has signed a deal for exclusive global rights to the latest version of the eCART predictive analytics score tool developed by Dr. Dana Edelson, Executive Medical Director of Rescue Care at the University of Chicago. The 'Lite' tool will be integrated into EarlySense's products and is the first ever scientifically validated early warning score to use only heart rate, respiratory rate and patient age, making it viable for use in conjunction with continuous monitoring sensors.
The eCART, was designed to identify risk of health deteriorations and cardiac arrests based on over 30 clinical data points per patient. It was developed using a data set of nearly 300,000 cases. The eCART tool has already been proven to improve care in hospitals and help clinicians achieve better outcomes, including lower mortality rates.
Used by healthcare facilities around the world, EarlySense assists clinicians in early detection of patient deterioration through the real-time collection of vital signs while patients lie in bed or sit in a chair. The company's FDA-cleared systems leverage Artificial Intelligence (AI) and big data analytics to provide actionable health insights and improve clinical outcomes while enhancing the patient experience through their passive collection approach. EarlySense solutions have been proven to help prevent adverse events, including code blues which are a result of cardiac or respiratory arrest, preventable ICU transfers, patient falls, pressure ulcers, and hospital readmissions. For more diagnoses, visit EarlySense.